Acadia Pharmaceuticals (ACAD) PT Lowered to $17 at Oppenheimer
Tweet Send to a Friend
(Updated - May 10, 2024 4:57 AM EDT)
Oppenheimer analyst Jay Olson lowered the price target on Acadia Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson lowered the price target on Acadia Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


